Search

Your search keyword '"Moccia, Marcello"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Moccia, Marcello" Remove constraint Author: "Moccia, Marcello" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
327 results on '"Moccia, Marcello"'

Search Results

1. Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod

3. Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project

6. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis

7. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

18. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

19. Multiple sclerosis progression: time for a new mechanism-driven framework

20. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

21. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020

22. Technological interventions in European dementia care: a systematic review of acceptance and attitudes among people living with dementia, caregivers, and healthcare workers.

23. Dysphagia assessment in patients with multiple sclerosis – an additional piece to disability burden.

24. Disability assessment using Google Maps

26. Radiological Reporting Systems in Multiple Sclerosis.

28. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study

29. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study

30. 2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis

32. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

35. Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study.

39. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis

46. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

50. Neurofilament in clinical practice: Is the multiple sclerosis community ready?

Catalog

Books, media, physical & digital resources